Search

Search Constraints

You searched for: Author/Creator Jarlier, Marta

Search Results

1. A recycling anti-transferrin receptor-1 monoclonal antibody as an efficient therapy for erythroleukemia through target up-regulation and antibody-dependent cytotoxic effector functions. Issue 3 (3rd April 2019)

2. An auristatin‐based antibody‐drug conjugate targeting HER3 enhances the radiation response in pancreatic cancer. Issue 7 (1st April 2019)

3. Anti-tumoral activity of the Pan-HER (Sym013) antibody mixture in gemcitabine-resistant pancreatic cancer models. Issue 1 (1st January 2021)

4. Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE). Issue 12 (2nd December 2022)

6. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early‐stage breast cancers. Issue 5 (28th August 2012)

7. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. Issue 1 (4th February 2019)

8. Importance of Patient Education for At-home Yoga Practice in Women With Hormonal Therapy-induced Pain During Adjuvant Breast Cancer Treatment: A Feasibility Study. (December 2021)

9. PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody. (3rd October 2017)

10. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. (28th September 2018)